Glucotrack, Inc. Announces Reverse Stock Split
Business Wire•22/10/2026•09:00 ET
0
Key Highlights
- ➤1-for-2 reverse split effective October 26, 2026, at Nasdaq opening
- ➤Outstanding shares reduced from 2,368,237 to approximately 1,184,119
- ➤Nasdaq exception requires $1.00 closing bid through November 9, 2026
- ➤Failure to satisfy exception terms could result in Nasdaq delisting
1-for-2 reverse stock split to become effective as of the opening of trading on October 26, 2026
Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a healthcare technology and biopharmaceutical company operating Lōkahi Therapeutics™, today announced that it will effect a 1-for-2 reverse stock split (the “Reverse Stock Split”) of its issued and outstanding common stock, par value $0.001 per share (the “Common Stock”), effective with the opening of trading on Monday, October 26, 2026.
Get started
Create a free account to read the full story.